Tag Archives: Myriad

PERSONALIZED MEDICINE TAKES OFF WHILE DIAGNOSTIC ASSAYS ARE GROUNDED

Posted on September 25, 2012 by Warren Woessner

A front-page article yesterday in the New York Times and other major newspapers reminded me that drug development and methods of medical treatment will be driven by the genomics of increasingly sub-divided patient populations. As reported by GenomeWeb, summarizing an … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , | Leave a comment

Akami/McKesson Decision Re-defines Induced Infringement

Posted on September 10, 2012 by Warren Woessner

In a 6-5 decision, the Fed. Cir., sitting en banc, decided two appeals which presented questions closely related to when an actor is liable for inducing infringement under 271(b); Akami Technologies, Inc. v. Limelight Networks, Inc. and McKesson Tech’s., Inc. … Continue reading →

Posted in Infringement | Tagged , , , , , , , , , | Leave a comment

AUTM Eastern Regional Meeting Panel to Address Patentability Challenges

Posted on September 10, 2012 by Warren Woessner

Warren Woessner will be joined by two other well-known patent attorneys,  Rodney Sparks of the University of Virginia Patent Foundation and Hans Sauer of BIO, in Philadelphia on September 13th. The panel will try to update the status of the major … Continue reading →

Posted in Miscellaneous | Tagged , , , , , , , , | Leave a comment

Chisum Patent Academy Announced 2013 Seminar Dates

Posted on August 22, 2012 by Warren Woessner

This seminar series, taught by Donald Chisum, the leading authority on evolution  in patent law, and my former law clerk, Prof. Janice Mueller, explore contemporary developments in patent law in detail.  How about a session on how to respond to … Continue reading →

Posted in Conferences and Classes | Tagged , , , , | Leave a comment